Dr. Carolin Thiele-Süß is a senior scientist at CureVac AG in Tübingen, Germany, where she focuses on the development of mRNA-based therapeutics. Carolin has contributed to several innovative projects in the field of mRNA technology. She holds a PhD in Organic Chemistry from Saarland University, with a research background in synthetic methodologies and pharmaceutical applications. Prior to joining CureVac, she conducted research at the Helmholtz Institute for Pharmaceutical Research Saarland, further strengthening her expertise in translational science and drug development. Her work has been published in peer-reviewed journals and she is a named inventor on multiple patents. Her interdisciplinary approach bridges organic chemistry, molecular biology, and therapeutic innovation.